PMA device
Rapid fFN for the TLiIQ System
Hologic, Inc. · Enzyme Immunoassay, Fetal Fibronectin (LKV, Class III) · First FDA decision Mar 9, 2001, newest May 21, 2021Pregnancy, labor and postpartum hemorrhage
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
1
Naming "Rapid fFN"
MAUDE reports
0
Brand "Rapid fFN", since 2015
PubMed studies
7
Mentioning "Rapid fFN"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Rapid fFN for the TLiIQ System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 3 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Rapid fFN", any status and sponsor, newest update first.
University of LiverpoolAcademic, hospital or other
NCT05837390 · 55 participants · Start Jul 6, 2023 · Primary completion Jan 31, 2025
Device: Cervical stiffness assessment · For: Preterm Birth
Sites: Liverpool, United Kingdom
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Rapid fFN", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LKV
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Rapid fFN"[tiab]. The summary above synthesizes these.
- Evaluation of quantitative fFn test in predicting the risk of preterm birth.
Centra M, Coata G, Picchiassi E, et al. · J Perinat Med · 2017
- Quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 1: Individual participant data meta-analysis and health economic analysis.
Stock SJ, Wotherspoon LM, Boyd KA, et al. · BMJ Open · 2018Meta-Analysis, Research Support, Non-U.S. Gov't
- Influence of transvaginal ultrasound examination on quantitative vaginal fibronectin measurements: a prospective evaluation study.
Golic M, Siedentopf JP, Pauly F, et al. · J Perinat Med · 2017
- Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis.
Deshpande SN, van Asselt AD, Tomini F, et al. · Health Technol Assess · 2013Research Support, Non-U.S. Gov't, Systematic Review
- The efficacy of quantitative fetal fibronectin in predicting spontaneous preterm birth in symptomatic women: A retrospective cohort study.
Nguyen AD, Liu CZ, Lehner C, et al. · Aust N Z J Obstet Gynaecol · 2019
- Study protocol: quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 2, UK Prospective Cohort Study.
Stock SJ, Wotherspoon LM, Boyd KA, et al. · BMJ Open · 2018Research Support, Non-U.S. Gov't
- The value of quantitative ultrasound tissue characterization of the cervix and rapid fetal fibronectin in predicting preterm delivery.
Tekesin I, Wallwiener D, Schmidt S · J Perinat Med · 2005Evaluation Study
Other devices of this type
Also filed under product code LKV.
- Fullterm Fetal Fibronectin TestHologic, Inc. · PMA 2008
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.